[HTML][HTML] Developing core outcome sets for clinical trials: issues to consider

PR Williamson, DG Altman, JM Blazeby, M Clarke… - Trials, 2012 - Springer
The selection of appropriate outcomes or domains is crucial when designing clinical trials in
order to compare directly the effects of different interventions in ways that minimize bias. If …

[HTML][HTML] The COMET handbook: version 1.0

PR Williamson, DG Altman, H Bagley, KL Barnes… - Trials, 2017 - Springer
The selection of appropriate outcomes is crucial when designing clinical trials in order to
compare the effects of different interventions directly. For the findings to influence policy and …

Guidelines for the management of oesophageal and gastric cancer

WH Allum, JM Blazeby, SM Griffin, D Cunningham… - Gut, 2011 - gut.bmj.com
STRUCTURE OF THE GUIDELINES The original guidelines described the management of
oesophageal and gastric cancer within existing practice. This paper updates the guidance to …

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

K Skivington, L Matthews, SA Simpson, P Craig, J Baird… - bmj, 2021 - bmj.com
The UK Medical Research Council's widely used guidance for developing and evaluating
complex interventions has been replaced by a new framework, commissioned jointly by the …

[HTML][HTML] Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer

JL Donovan, FC Hamdy, JA Lane… - … England Journal of …, 2016 - Mass Medical Soc
Background Robust data on patient-reported outcome measures comparing treatments for
clinically localized prostate cancer are lacking. We investigated the effects of active …

The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care

M Groenvold, MA Petersen, NK Aaronson… - european Journal of …, 2006 - Elsevier
This study aimed at developing a shortened version of the EORTC QLQ-C30, one of the
most widely used health-related quality of life questionnaires in oncology, for palliative care …

Challenges in evaluating surgical innovation

PL Ergina, JA Cook, JM Blazeby, I Boutron, PA Clavien… - The Lancet, 2009 - thelancet.com
Research on surgical interventions is associated with several methodological and practical
challenges of which few, if any, apply only to surgery. However, surgical evaluation is …

[HTML][HTML] Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

HER Ford, A Marshall, JA Bridgewater… - The lancet …, 2014 - thelancet.com
Background Second-line chemotherapy for patients with oesophagogastric adenocarcinoma
refractory to platinum and fluoropyrimidines has not shown benefits in health-related quality …

[HTML][HTML] Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update

K Skivington, L Matthews, SA Simpson… - Health technology …, 2021 - ncbi.nlm.nih.gov
Background The Medical Research Council published the second edition of its framework in
2006 on developing and evaluating complex interventions. Since then, there have been …

[HTML][HTML] Core outcome Set-STAndards for development: the COS-STAD recommendations

JJ Kirkham, K Davis, DG Altman, JM Blazeby… - PLoS …, 2017 - journals.plos.org
Background The use of core outcome sets (COS) ensures that researchers measure and
report those outcomes that are most likely to be relevant to users of their research. Several …